(Total Views: 602)
Posted On: 12/18/2020 7:30:27 PM
Post# of 145250
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Rubraquercus #68822
“ why is 300,000 doses of drug on the shelf not considered an asset for the purpose of nasdaq”
At the risk of pointing out the obvious: a drug that you can’t sell (regardless of how much you have) isn’t worth anything - and in fact may have carrying costs that give it a negative value until it can be sold.
My hunch is we won’t see any progress on uplisting prior to an EUA.
Read More: https://investorshangout.com/post/newpost/605...z6h1cbkkhU
At the risk of pointing out the obvious: a drug that you can’t sell (regardless of how much you have) isn’t worth anything - and in fact may have carrying costs that give it a negative value until it can be sold.
My hunch is we won’t see any progress on uplisting prior to an EUA.
Read More: https://investorshangout.com/post/newpost/605...z6h1cbkkhU
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)